MOLN · Health & biotech
Molecular Partners AG -Adr
Jun 30, 2026CUSIP 60853G106
13F filers holding5 +25%
Concentrated funds holding2
Concentrated funds: opened · sold out0 · 0
Holders
By value held at Jun 30, 2026| Fund | % of fund | Value | Shares | Since Q1 2026 |
|---|---|---|---|---|
| Montanova Capital, LLCconcentrated | 0.18% | $8.6M | 2,221,494 | Held |
| Bvf Inc/Ilconcentrated | 0.13% | $5.1M | 1,353,968 | Held |
| Citadel Advisors LLC | 0.00% | $65.3K | 17,179 | New |
| Morgan Stanley | 0.00% | $1.4K | 367 | Held |
| UBS Group AG | 0.00% | $1.1K | 279 | New |